in

CAR T-Cell Therapy Drives Refractory SLE Into Remission

CAR T-Cell Therapy Drives Refractory SLE Into Remission

B-cell depletion with chimeric antigen receptor T cells induced both serologic and clinical remissions in a patient with treatment-resistant lupus. Medscape Medical News
Read More

What do you think?

Written by Margarete Michaud

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

AHA Urges Greater Attention to Peripheral Artery Disease

AHA Urges Greater Attention to Peripheral Artery Disease

Largest U.S. teachers’ union supports mandatory COVID vaccination

Largest U.S. teachers’ union supports mandatory COVID vaccination